Dupixent Europese Unie - Nederlands - EMA (European Medicines Agency)

dupixent

sanofi winthrop industrie - dupilumab - dermatitis, atopic; prurigo; esophageal diseases; asthma; sinusitis - middelen voor dermatitis, met uitzondering van corticosteroïden - atopic dermatitisadults and adolescentsdupixent is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. children 6 months to 11 years of agedupixent is indicated for the treatment of severe atopic dermatitis in children 6 months to 11 years old who are candidates for systemic therapy. asthmaadults and adolescentsdupixent is indicated in adults and adolescents 12 years and older as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), see section 5. 1, who are inadequately controlled with high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. children 6 to 11 years of agedupixent is indicated in children 6 to 11 years old as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), who are inadequately controlled with medium to high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. chronic rhinosinusitis with nasal polyposis (crswnp)dupixent is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control. prurigo nodularis (pn)dupixent is indicated for the treatment of adults with moderate-to-severe prurigo nodularis (pn) who are candidates for systemic therapy. eosinophilic esophagitis (eoe)dupixent is indicated for the treatment of eosinophilic esophagitis in adults and adolescents 12 years and older, weighing at least 40 kg, who are inadequately controlled by, are intolerant to, or who are not candidates for conventional medicinal therapy.

Insulin Human Winthrop Europese Unie - Nederlands - EMA (European Medicines Agency)

insulin human winthrop

sanofi-aventis deutschland gmbh - insulin human - suikerziekte - geneesmiddelen die worden gebruikt bij diabetes - diabetes mellitus waarbij behandeling met insuline vereist is. insulin human winthrop rapid is ook geschikt voor de behandeling van hyperglykemische coma en ketoacidose, evenals voor het bereiken van pre-, intra- en postoperatieve stabilisatie bij patiënten met diabetes mellitus.

Frisium 10 mg tabl. België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

frisium 10 mg tabl.

sanofi belgium sa-nv - clobazam 10 mg - tablet - 10 mg - clobazam 10 mg - clobazam

Frisium 20 mg tabl. België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

frisium 20 mg tabl.

sanofi belgium sa-nv - clobazam 20 mg - tablet - 20 mg - clobazam 20 mg - clobazam

Lasix 500 mg, tabletten Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

lasix 500 mg, tabletten

medcor pharmaceuticals b.v. artemisweg 232 8239 de lelystad - furosemide 500 mg/stuk - tablet - cellulose, gepoederd (e 460) ; chinolinegeel (e 104) ; lactose 1-water ; magnesiumstearaat (e 470b) ; maÏszetmeel ; natriumzetmeelglycolaat ; siliciumdioxide (e 551) ; talk (e 553 b), cellulose, gepoederd (e 460) ; chinolinegeel (e 104) ; lactose 1-water ; magnesiumstearaat (e 470b) ; maÏszetmeel ; natriumzetmeelglycolaat (e468) ; siliciumdioxide (e 551) ; talk (e 553 b), - furosemide

Lasix 500, tabletten 500 mg Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

lasix 500, tabletten 500 mg

genzyme europe b.v. paasheuvelweg 25 1105 bp amsterdam - furosemide 500 mg/stuk - tablet - cellulose, gepoederd (e 460) ; chinolinegeel (e 104) ; lactose 1-water ; magnesiumstearaat (e 470b) ; maÏszetmeel ; natriumzetmeelglycolaat ; siliciumdioxide (e 551) ; talk (e 553 b), cellulose, gepoederd (e 460) ; chinolinegeel (e 104) ; lactose 1-water ; magnesiumstearaat (e 470b) ; maÏszetmeel ; natriumzetmeelglycolaat (e468) ; siliciumdioxide (e 551) ; talk (e 553 b), - furosemide

Amaryl 1 mg, tabletten Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

amaryl 1 mg, tabletten

genzyme europe b.v. paasheuvelweg 25 1105 bp amsterdam - glimepiride 1 mg/stuk - tablet - cellulose, microkristallijn (e 460) ; ijzeroxide rood (e 172) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; povidon (e 1201), cellulose, microkristallijn (e 460) ; ijzeroxide rood (e 172) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat (e468) ; povidon (e 1201), - glimepiride

Amaryl 2 mg, tabletten Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

amaryl 2 mg, tabletten

genzyme europe b.v. paasheuvelweg 25 1105 bp amsterdam - glimepiride 2 mg/stuk - tablet - cellulose, microkristallijn (e 460) ; ijzeroxide geel (e 172) ; indigokarmijn aluminiumlak (e 132) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; povidon (e 1201), cellulose, microkristallijn (e 460) ; ijzeroxide geel (e 172) ; indigokarmijn aluminiumlak (e 132) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat (e468) ; povidon (e 1201), - glimepiride

Amaryl 3 mg, tabletten Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

amaryl 3 mg, tabletten

genzyme europe b.v. paasheuvelweg 25 1105 bp amsterdam - glimepiride 3 mg/stuk - tablet - cellulose, microkristallijn (e 460) ; ijzeroxide geel (e 172) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; povidon (e 1201), cellulose, microkristallijn (e 460) ; ijzeroxide geel (e 172) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat (e468) ; povidon (e 1201), - glimepiride

Amaryl 4 mg, tabletten Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

amaryl 4 mg, tabletten

genzyme europe b.v. paasheuvelweg 25 1105 bp amsterdam - glimepiride 4 mg/stuk - tablet - cellulose, microkristallijn (e 460) ; indigokarmijn aluminiumlak (e 132) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; povidon (e 1201), cellulose, microkristallijn (e 460) ; indigokarmijn aluminiumlak (e 132) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat (e468) ; povidon (e 1201), - glimepiride